August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.
May 1, 2024
Yahoo News featured comments from the University of Cincinnati's Rekha Chaudhary in a story about rising rates of diagnoses and deaths from colorectal cancers among young people.
August 11, 2021
Researchers at the University of Cincinnati College of Medicine have developed a computerized decision analytic model to compare projected outcomes of three vaccine strategies: a patient opts for a messenger RNA vaccine, a patient decides to get an adenovirus vector vaccine or the patient simply forgoes a vaccine altogether.
February 22, 2022
Health experts in the United States are monitoring an increase in cases of bird flu in several states, including Indiana, Kentucky and Virginia. In January, the United States Department of Agriculture detected the first U.S. bird flu case after a hunted wild bird tested positive for the virus in Colleton County, South Carolina. Experts reported that it was the H5N1 strain, a highly pathogenic avian influenza virus (HPAI) — the same strain responsible for fatal poultry outbreaks across Europe and Asia in late 2021. In a story on the increase in bird flu published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited.
August 27, 2021
The school year rapidly approaches amid a surge in pediatric COVID-19 hospitalizations, and parents desperately want to know: When can young children get the vaccine? UC's Carl Fichtenbaum weighs in.
September 24, 2021
In overweight and obese adults at high cardiovascular risk, once-daily subcutaneous liraglutide plus changes in diet and physical activity reduced visceral fat, a single-center phase 4 placebo-controlled trial showed. Vincent Fong, MD, was interviewed for his reaction to the study by Medscape.
November 29, 2021
Over the Thanksgiving weekend, the World Health Organization gave the name omicron to the newest identified version of SARS-CoV-2 and called it a variant of concern. There is still much to be learned about this latest variant and how potentially dangerous it is. In a story on the variant, Cincinnati.com interview Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
November 19, 2021
In a story for Reuters Health published by Medscape, it was reported that Type 2 diabetes subtypes have partially distinct genetic backgrounds, suggesting etiological differences that may one day be targeted for treatment. That was the conclusion of genome-wide association analyses. Shailendra Patel, MD, PhD, professor and director of the Division of Endocrinology, Diabetes and Metabolism in the Department of Internal Medicine at the UC College of Medicine provided reaction to the study.
March 9, 2022
COVID-19 first entered the public consciousness about two years ago. It drew a lot of comparisons to another pandemic just over a hundred years earlier. WVXU interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to learn more about how the COVID-19 outbreak compares with the 1918 influenza outbreak.